<p>In the group of patients with a final serum P<4.5 mg/dL, 54, 80, 80, 80, 100 and 100% of them had a ranged serum phosphate below the target at week 0, 8, 16, 24, 32 and 40 respectively. On the contrary, in the group with a final serum phosphate >4.5 mg/dl, 66, 77, 44, 44, 33 and 0% of the patients had serum phosphate levels below the study target along the study period. Dots represent median and whiskers represent IQR. * Between-group differences <i>P</i><0.05. <sup><b>+</b></sup> Within-group differences <i>P</i><0.05 for different groups. <sup><b>#</b></sup> <i>P</i><0.001 for global comparison of curves.</p
<p>Mean (SD) unless otherwise specified.</p><p>*p-values for comparison of change from baseline to 1...
Abstract Background Hyperphosphataemia in dialysis subjects is associated with increased mortality. ...
<p>Kaplan-Meier curve for 28 day in-hospital mortality in patients with hyperphosphatemia (grey line...
<p>Statistical testing shows group comparison of patients with hypophosphatemia (n = 480) and hyperp...
<p>Patients are divided according to final serum phosphate, below or above 4.5 mg/dL. All patients w...
<p><b>a)</b> 3.4 mg/dL, <b>b)</b> 3.6 mg/dL, <b>c)</b> 3.8 mg/dL, <b>d)</b> 4.0 mg/dL of serum phosp...
<p>Simple linear correlations between the percent change in serum phosphate concentration, both FGF2...
Serial changes in the median (25th, 75th percentile) of serum levels of corrected Ca, phosphate, and...
<p>Values are expressed as means ± SD. *Significant differences (<i>P</i><0.05) compared with pre-ex...
<p>Group 1 (phosphate decrease group), ≥-1.3 mg/dL decrease; group 2 (stable group), -1.3 to 0 mg/dL...
<p>Data are expressed as means ± SD or as median and interquartile range.</p><p>* = p<0.05, minimum ...
BACKGROUND: Serum phosphate is a key parameter in the management of chronic kidney disease-mineral a...
<p>(A) Serum corrected calcium concentrations (white bars) and inorganic phosphate concentrations (b...
<p>25 (OH) D, s-25-hydroxyvitamin D; 1,25 (OH)<sub>2</sub>D, s- 1,25 dihydroxyvitamin D; PTH, p-para...
The aim of this study was to find out the ideal cut-off level of phosphate for safe healing when def...
<p>Mean (SD) unless otherwise specified.</p><p>*p-values for comparison of change from baseline to 1...
Abstract Background Hyperphosphataemia in dialysis subjects is associated with increased mortality. ...
<p>Kaplan-Meier curve for 28 day in-hospital mortality in patients with hyperphosphatemia (grey line...
<p>Statistical testing shows group comparison of patients with hypophosphatemia (n = 480) and hyperp...
<p>Patients are divided according to final serum phosphate, below or above 4.5 mg/dL. All patients w...
<p><b>a)</b> 3.4 mg/dL, <b>b)</b> 3.6 mg/dL, <b>c)</b> 3.8 mg/dL, <b>d)</b> 4.0 mg/dL of serum phosp...
<p>Simple linear correlations between the percent change in serum phosphate concentration, both FGF2...
Serial changes in the median (25th, 75th percentile) of serum levels of corrected Ca, phosphate, and...
<p>Values are expressed as means ± SD. *Significant differences (<i>P</i><0.05) compared with pre-ex...
<p>Group 1 (phosphate decrease group), ≥-1.3 mg/dL decrease; group 2 (stable group), -1.3 to 0 mg/dL...
<p>Data are expressed as means ± SD or as median and interquartile range.</p><p>* = p<0.05, minimum ...
BACKGROUND: Serum phosphate is a key parameter in the management of chronic kidney disease-mineral a...
<p>(A) Serum corrected calcium concentrations (white bars) and inorganic phosphate concentrations (b...
<p>25 (OH) D, s-25-hydroxyvitamin D; 1,25 (OH)<sub>2</sub>D, s- 1,25 dihydroxyvitamin D; PTH, p-para...
The aim of this study was to find out the ideal cut-off level of phosphate for safe healing when def...
<p>Mean (SD) unless otherwise specified.</p><p>*p-values for comparison of change from baseline to 1...
Abstract Background Hyperphosphataemia in dialysis subjects is associated with increased mortality. ...
<p>Kaplan-Meier curve for 28 day in-hospital mortality in patients with hyperphosphatemia (grey line...